← Evidence map

ArticleCase reports in rheumatology2023

Usefulness of Sarilumab in Patients with Rheumatoid Arthritis after Regression of Lymphoproliferative Disorders.

Yoshifumi Tada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39262417